Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Spectrum Pharma Inc (SPPI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,079,217
  • Shares Outstanding, K 111,836
  • Annual Sales, $ 109,330 K
  • Annual Income, $ -120,010 K
  • 60-Month Beta 2.70
  • Price/Sales 9.63
  • Price/Cash Flow N/A
  • Price/Book 3.55

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.27
  • Number of Estimates 1
  • High Estimate -0.27
  • Low Estimate -0.27
  • Prior Year -0.19
  • Growth Rate Est. (year over year) -42.11%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.19 +2.72%
on 04/23/19
11.36 -16.90%
on 04/08/19
-0.13 (-1.36%)
since 03/22/19
3-Month
8.87 +6.43%
on 03/15/19
12.15 -22.30%
on 02/25/19
-1.40 (-12.92%)
since 01/24/19
52-Week
6.22 +51.77%
on 12/20/18
25.29 -62.67%
on 08/27/18
-7.90 (-45.56%)
since 04/24/18

Most Recent Stories

More News
Shares of Biocryst Pharm Rank the Highest in Terms of Relative Performance in the Biotechnology Industry (BCRX , SPPI , KPTI , NVTA , NTRA )

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

SPPI : 9.44 (-2.18%)
BCRX : 7.99 (-1.84%)
KPTI : 4.86 (-2.41%)
Spectrum Pharmaceuticals to Present Corporate Update at the H.C. Wainwright Global Life Sciences Conference on April 9

Spectrum Pharmaceuticals (NasdaqGS: SPPI), announced today that an overview of the company's business strategy and development-stage programs will be given at the H.C. Wainwright Global Life...

SPPI : 9.44 (-2.18%)
Why Is Spectrum Pharma (SPPI) Down 1.1% Since Last Earnings Report?

Spectrum Pharma (SPPI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

SPPI : 9.44 (-2.18%)
Interesting SPPI Put And Call Options For November 15th

Investors in Spectrum Pharmaceuticals Inc saw new options become available this week, for the November 15th expiration. One of the key inputs that goes into the price an option buyer is willing to pay,...

SPPI : 9.44 (-2.18%)
Report: Exploring Fundamental Drivers Behind ON Semiconductor, Pilgrim's Pride, Merck & Co., Healthcare Services Group, Genomic Health, and Spectrum Pharmaceuticals -- New Horizons, Emerging Trends, and Upcoming Developments

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ON Semiconductor Corporation...

SPPI : 9.44 (-2.18%)
PPC : 26.71 (+2.26%)
GHDX : 65.12 (-1.23%)
MRK : 74.73 (+0.17%)
HCSG : 34.06 (+0.21%)
ON : 23.02 (+1.86%)
Spectrum Pharma (SPPI) Withdraws Rolontis BLA, Shares Down

Spectrum Pharma (SPPI) withdraws the BLA seeking approval for Rolontis, as the FDA requests for additional manufacturing-related data.

SPPI : 9.44 (-2.18%)
AITB : 4.7200 (-2.68%)
INFI : 1.55 (-1.27%)
AMGN : 178.30 (-0.81%)
Spectrum Pharmaceuticals Provides BLA Filing Update for ROLONTIS(R) (eflapegrastim)

Spectrum Pharmaceuticals, Inc. (NASDAQ-GS: SPPI) announced today that due to the U.S. Food and Drug Administration's (FDA) request for additional manufacturing-related information for ROLONTIS,...

SPPI : 9.44 (-2.18%)
Ligand Sells Promacta Rights for $827M, Updates '19 View

Ligand Pharmaceuticals (LGND) announces sale of all rights to Novartis' Promacta, including royalty payments on global sales, to Royalty Pharma.

SPPI : 9.44 (-2.18%)
LGND : 123.85 (-3.53%)
NVS : 77.82 (+2.53%)
AMGN : 178.30 (-0.81%)
Spectrum Pharmaceuticals Announces the Completion of the Sale of its Marketed Portfolio

Spectrum Pharmaceuticals, Inc. (NASDAQ-GS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today completed the sale of its portfolio of seven FDA-approved...

SPPI : 9.44 (-2.18%)
First Week of SPPI April 18th Options Trading

Investors in Spectrum Pharmaceuticals Inc saw new options become available this week, for the April 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SPPI...

SPPI : 9.44 (-2.18%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade SPPI with:

Business Summary

Spectrum Pharmaceuticals, Inc. is opportunistically acquiring and advancing a diversified portfolio of oncology drug candidates that meet critical health challenges for which there are few other treatment options. Spectrum's expertise lies in identifying undervalued drugs with demonstrated safety and...

See More

Key Turning Points

2nd Resistance Point 9.89
1st Resistance Point 9.67
Last Price 9.44
1st Support Level 9.28
2nd Support Level 9.11

See More

52-Week High 25.29
Fibonacci 61.8% 18.01
Fibonacci 50% 15.76
Fibonacci 38.2% 13.50
Last Price 9.44
52-Week Low 6.22

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar